Alzheimer's disease (AD) is an age-associated neurodegenerative disorder that is associated with a progressive impairment of cognition. Acupuncture has protective effects, although the molecular mechanisms are largely unknown. The activation of peroxisome proliferator activated receptor γ (PPAR-γ) has an impact on the pathogenesis of AD.
Objective
To test the hypothesis that electroacupuncture (EA) confers therapeutic benefits through activation of PPAR-γ in a rat model of AD.
Methods
80 male Sprague-Dawley rats were randomly divided into four groups (n=20 each): Control (healthy control group), Sham (sham-operated group), AD (untreated AD model group), and AD+EA (AD model group treated with EA). The AD model was induced in the latter two groups by injection of amyloid-β (Aβ)1-40 into the hippocampal CA1 area bilaterally. EA was administered at GV20 and BL23 six times per week for 4 weeks. The rats’ behaviour was examined using the Morris water maze test, and protein expression of Aβ, hyperphosphorylated tau protein (p-Tau), PPAR-γ, and hyperphosphorylated p38 mitogen activated protein kinase (p38MAPK) in the hippocampal CA1 region was examined by immunohistochemistry and Western blotting.
Results
EA significantly improved cognitive deficits and reduced Aβ and p-Tau Ser404 protein concentrations in the hippocampal CA1 region. AD decreased PPAR-γ and increased p-p38MAPK, while EA significantly upregulated PPAR-γ expression and significantly downregulated p-p38MAPK expression.
Conclusions
Acupuncture at GV20 and BL23 might have a beneficial effect on rats with AD via activation of PPAR-γ and inhibition of p-p38MAPK expression.
PrinceM, BryceaR, AlbaneseaE, The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement2013;9:63–75.
2.
YuanJ, ZhangZ, WenH, Incidence of dementia and subtypes: a cohort study in four regions in China. Alzheimers Dement2016;12:262–71.
3.
GoldM, EL KhouryJ.β-amyloid, microglia, and the inflammasome in Alzheimer's disease. Semin Immunopathol2015;37:607–11.
4.
Aguirre-RuedaD, Guerra-OjedaS, AldasoroM, Astrocytes protect neurons from Aβ1-42 peptide-induced neurotoxicity increasing TFAM and PGC-1 and decreasing PPAR-γ and SIRT-1. Int J Med Sci2015;12:48–56.
5.
SodhiRK, SinghN, JaggiAS. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol2011;384:115–24.
6.
AubertRE, HerreraV, ChenW, Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes. Diabetes Obes Metab2010;12:716–21.
7.
WangAT, SmithSA. In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone. Ann Intern Med2010;153:6–11.
8.
PengXW, DongKL. [Clinical observation on acupuncture combined with Yizhi Jiannao granules for treatment of Alzheimer's disease]. Zhongguo Zhen Jiu2009;29:269–71.
9.
ZhuH, DongKL, WuY, [Influence of acupuncture on isoprostane in patients with Alzheimer's disease]. Zhongguo Zhen Jiu2010;30:18–21.
10.
LiG, ZhangX, ChengH, Acupuncture improves cognitive deficits and increases neuron density of the hippocampus in middle-aged SAMP8 mice. Acupunct Med2012;30:339–45.
11.
LeungMC, YipKK, HoYS, Mechanisms underlying the effect of acupuncture on cognitive improvement: a systematic review of animal studies. J Neuroimmune Pharmacol2014;9:492–507.
12.
FangJQ, ZhuSX, ZhangY.Effect of electroacupuncture on expression of phosphorylated P38MAPK and IL-1 in frontal lobe and hippocampus in rat with Alzheimer's disease. Zhen Ci Yan Jiu2013;38:35–9.
13.
XueWG, ZhangZ, XuH, [Effect of electroacupuncture on learning-memory ability, and Abeta and LRP1 immunoactivity in hippocampal sulcus microvessels in APP transgenic mice]. Zhen Ci Yan Jiu2011;36:95–100.
14.
DengJ, LvE, YangJ, Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model. J Neuroinflammation2015;12:103.
15.
XueMQ, LiuXX, ZhangYL, Nicotine exerts neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signalling pathway. Int J Mol Med2014;33:925–33.
16.
WangS, ZhangC, ShengX, Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases. J Clin Neurosci2014;21:810–14.
DengCL, YinKJ. Experimental acupuncture. People's Health Publishing House, 1998:142–3.
19.
ChangRC, ChiuK, HoYS, Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation. Cell Mol Immunol2009;6:317–26.
20.
ElaliA, RiverstS.Microglia in Alzheimer's disease: a multifaceted relationship. Brain Behav Immun2016;55:138–50.
21.
CooperNR, BradtBM, O'BarrS, Focal inflammation in the brain: role in Alzheimer's disease. Immunol Res2000;21:159–65.
22.
AguzziA, BarresBA, BennettML. Microglia: scapegoat, saboteur, or something else. Science2013;339:156–61.
23.
SudduthTL, SchmittFA, NelsonPT, Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol Aging2013;34:1051–9.
24.
CameronB, LandrethGE. Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis2010:37:503–9.
NeherMD, WeckbachS, Huber-LangMS, New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury. PPAR Res2012;2012:728461.
27.
BenedettiE, D'AngeloB, CristianoL, Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signalling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE). Cell Cycle2014;13:1335–44.
28.
DinamarcaMC, RíosJA, InestrosaNC. Postsynaptic receptors for amyloid-β oligomers as mediators of neuronal damage in Alzheimer's disease. Front Physiol2014;3:464.
29.
Mandrekar-ColucciS, KarloJC, LandrethGE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci2012;32:10117–28.
30.
FuenzalidaK, QuintanillaR, RamosP, Peroxisome proliferator-activated receptor up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem2007;282:37006–15.
31.
HaglandHR, NilssonLI, BurriL, Induction of mitochondrial biogenesis and respiration is associated with mTOR regulation in hepatocytes of rats treated with the pan-PPAR activator tetradecylthioacetic acid (TTA). Biochem Biophys Res Commun2013;430:573–8.
32.
UmHS, KangEB, KooJH, Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neurosci Res2011;69:161–73.
33.
KimEK, ChoiEJ. Pathological roles of MAPK signalling pathways in human diseases. Biochim Biophys Acta2010;1802:396–405.
34.
WanZX, MahD, SimtchoukS, Globular adiponectin induces a pro-inflammatory response in human astrocytic cells. BBRC2014;446:37–42.
35.
TaiLM, HollowayKA, MaleDK, Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med2010;14:1101–12.
36.
ChenX, LinR, ChangL, Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, step and caspase-3. Neurosci2013;253:435–43.
37.
VictorNA, WanderiEW, GamboaJ, Altered PPAR gamma expression and activation after transient focal ischemia in rats. Eur J Neurosci2006;24:1653–63.
38.
FanelliF, SepeS, D'AmelioM, Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol Neurodegener2013;8:8.
39.
HenekaMT, Reyes-IrisarriE, HüllM, Impact and therapeutic potential of PPARs in Alzheimer's disease. Curr Neuropharmacol2011;9:643–50.
40.
DennerLA, Rodriguez-RiveraJ, HaidacherSJ, Cognitive enhancement with rosiglitazone links the hippocampal PPAR-γ and ERK MAPK signalling pathways. J Neurosci2012;32:16725–35.
